A defibrillator isn’t just a defibrillator.

Medtronic offers a full line of implantable cardioverter defibrillators (ICDs) and services for treating your patients with tachyarrhythmias. Our broad range of ICDs can provide individualized treatment utilizing ICD leads with proven reliability and the nation’s leading remote monitoring platform, the Medtronic CareLink™ network.1

ICD systems

People are unique. Our ICD portfolio is too. It includes both transvenous ICDs and a first-of-its-kind extravascular ICD offering antitachycardia pacing (ATP). Medtronic is revolutionizing defibrillation technology and delivering products and features to improve productivity and support clinic efficiency, and help manage patients’ tachyarrhythmias.

Managing your patients

Our advanced therapies, monitoring solutions, and management services are designed to help your patients feel better, while improving the efficiency and effectiveness of care when treating tachyarrhythmias.2

Heart Device Answers

Share the HeartDeviceAnswers.com website with your patients who are considering an implantable heart device. Once on the site, patients can simply type in a word, phrase, or question, or explore a list of topics to find the answers they‘re looking for.

Reduce complications

Reducing procedure-related complications is now more important than ever. Learn about the TYRX™ absorbable antibacterial envelope, an innovative solution aimed to improve procedure-related outcomes.3


Resources

Products

Filter by
  1. Devices supported on the CareLink network. January 2014. Data on file.
  2. Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. 2004;110(17):2591–2596. doi: 10.1161/01.CIR.0000145610.64014.E4.
  3. Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med. 2019;380(20):1895–1905. doi: 10.1056/NEJMoa1901111.